[Research Progress of Ras/Raf/MEK/ERK Signaling Pathways in Leukemia-Review]

Jing Liu1, Na Lv1, Yong-Hui Li1

  • 1Medical College of Chinese PLA, Department of Hematology of Chinese PLA General Hospital, Beijing 100853, China.

Insights

Targeting the Ras/Raf/MEK/ERK pathway with inhibitors is a promising new strategy for leukemia treatment. Recent research, including in vitro, in vivo, and early clinical studies, shows significant therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • The Ras/Raf/MEK/ERK signaling pathway is crucial in leukemia development.
  • Targeting this pathway presents a novel therapeutic strategy for leukemia.

Purpose of the Study:

  • To review recent advances in understanding the Ras/Raf/MEK/ERK pathway's role in leukemia.
  • To highlight the therapeutic potential of pathway inhibitors in leukemia treatment.

Main Methods:

  • Literature review of in vitro and in vivo studies.
  • Analysis of early clinical trial data.
  • Focus on inhibitors targeting key signaling components.

Main Results:

  • Inhibitors of the Ras/Raf/MEK/ERK pathway show efficacy in preclinical models.
  • Early clinical studies indicate positive outcomes and therapeutic prospects.
  • Pathway inhibition is an emerging and effective treatment strategy.

Conclusions:

  • The Ras/Raf/MEK/ERK pathway is a validated target for leukemia therapy.
  • Inhibitors targeting this pathway demonstrate significant therapeutic promise.
  • Further research and clinical application of these inhibitors are warranted.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.5K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
9.8K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.1K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.8K